Lung Cancer
Lung Cancer
Advertisement
Kaitlyn KoskoLung Cancer | March 28, 2024
Opportunistic screening for lung cancer helped lower the risk of death related to the disease in China.
Read More
Kaitlyn KoskoLung Cancer | March 28, 2024
Low-dose computed tomography can reduce the number of deaths from lung cancer in Brazil.
Kaitlyn KoskoNon-Small Cell Lung Cancer | March 28, 2024
The use of tobacco negatively affects survival outcomes in patients with advanced NSCLC.
Kaitlyn KoskoNon-Small Cell Lung Cancer | March 28, 2024
Patients with EGFR-positive metastatic NSCLC whose disease progressed following first-line treatment have worse outcomes.
Kaitlyn KoskoNon-Small Cell Lung Cancer | March 28, 2024
Patient selection for perioperative immunotherapies may be determined by specific intratumoral immune cells.
Mary GreccoNon-Small Cell Lung Cancer | March 28, 2024
A study explored the potential benefits of combining first-generation EGFR-TKI with chemotherapy as neoadjuvant treatment.
Mary GreccoSmall Cell Lung Cancer | March 26, 2024
Chemotherapy-induced myelosuppression among patients with extensive-stage SCLC is poorly understood.
Mary GreccoNon-Small Cell Lung Cancer | March 26, 2024
The VISION study that evaluated pre/post-tepotinib treatment in advanced/metastatic METex14 skipping NSCLC.
Mary GreccoSmall Cell Lung Cancer | March 26, 2024
The DeLLphi-301 study that evaluated patients with advanced SCLC.
Arun KrishnaNon-Small Cell Lung Cancer | March 26, 2024
Arun Krishna, of AstraZeneca, talks about the LAURA Phase III trial, which assessed Tagrisso in NSCLC patients.
Mary GreccoNon-Small Cell Lung Cancer | March 25, 2024
Results of a study that evaluated the impact of comprehensive versus limited NGS for advanced NSCLC.
Mary GreccoNon-Small Cell Lung Cancer | March 25, 2024
A study evaluated second-line treatment patterns and clinical outcomes of IO in NSCLC.
Mary GreccoNon-Small Cell Lung Cancer | March 25, 2024
Patients with metastatic NSCLC who receive first-line anti-PD-L1-based IO may achieve durable disease control.
Mary GreccoSmall Cell Carcinoma | March 22, 2024
Lurbinectedin monotherapy is currently being studied in Jazz EMERGE 402 study in patients with metastatic SCLC.
Kaitlyn KoskoMesothelioma | March 22, 2024
A complete residential history should be reviewed following a mesothelioma diagnosis.
Kaitlyn KoskoLung Cancer | March 22, 2024
Patients with lung cancer who were treated with ICIs and developed TRL had poorer survival outcomes.
Kaitlyn KoskoLung Cancer | March 22, 2024
Individuals with poor sleep quality are more likely to get lung cancer than those with good sleep quality.
Rob DillardLung Cancer | March 21, 2024
Bronchoalveolar lavage supernatant may serve as a possible target in early-stage lung cancer research, a recent study showed.
Kaitlyn KoskoNon-Small Cell Lung Cancer | March 21, 2024
Researchers created a novel prediction model that can forecast OS in patients with adenocarcinoma.
Mary GreccoNon-Small Cell Lung Cancer | March 21, 2024
Black and/or socioeconomically disadvantaged patients with advanced NSCLC have higher mortality rates.
Advertisement
Advertisement
Advertisement
Latest News

March 28, 2024